Dennis M. Lanfear - President & CEO, Director at Coherus Oncology, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director
Issuer Symbol
CHRS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Dennis M. Lanfear since 06 Mar 2025

Holdings reported by Dennis M. Lanfear for Coherus Oncology, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,048,235 $1,488,493 $1.42 23 Jan 2026 Direct
Common Stock 432,684 $614,411 $1.42 23 Jan 2026 By Trust
Common Stock 86,965 $123,490 $1.42 23 Jan 2026 By LLC
Stock Option (Right to Buy) 750,000 23 Jan 2026 Direct Common Stock

Transactions reported by Dennis M. Lanfear for Coherus Oncology, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.